Biokey International Inc (BKYI)

[iam4]

I read that article, and I must admit that it's good to see BIO-key in the company of IBM, Alphabet, etc., even IF BKYI is in the micro-cap category.

It has been interesting to watch this stock climb over recent days.

On the other hand, I don't remember seeing any PR regarding any new large customer acquisition. If BIO-key can hit even the low end of their $6M - $12M guidance, then they'll have survived a tough year and come out smiling.

The issue that I foresee, and I absolutely expect to hear about it on the 2019 earnings call, is that BIO-key made the switch from perpetual to subscription-based licensing, which will cost them around 60% of recognizable revenue this year.

This is unavoidable, BUT I've done it, and if you can build an ARR model, then you are financially set, and you may even grow.

THAT is what I want to hear. If ARR is not significant, then 2020 will be brutal.